The efficacy and safety of apixaban: what has changed in 12 years of its use in real clinical practice?
This review examines the position of apixaban among other direct oral anticoagulants in patients with atrial fibrillation (AF) and venous thrombosis in randomized clinical trials and real clinical practice. Since the advent of apixaban, many studies of real clinical practice (RCP) and meta-analyses...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
«REMEDIUM GROUP» Ltd.
2023-08-01
|
| Edice: | Атеротромбоз |
| Témata: | |
| On-line přístup: | https://www.aterotromboz.ru/jour/article/view/298 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|